Gene · 1723
Papers2,016
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,016
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FZD7 Inhibitor SRI Attenuates High Glucose-Induced Retinal Pigment Epithelial Cell Injury Accompanied by Ferroptosis-Associated Changes via Suppression of the Wnt/β-Catenin Pathway. | Endocrinol Diabetes Metab | 2026 | 42487268 | PubTator, text mining | PubMed |
| Vidofludimus calcium for the treatment of multiple sclerosis: development rationale, mechanism of action, and early trial data. | Expert Opin Investig Drugs | 2026 | 42461014 | PubTator, text mining | PubMed |
| The role of ferroptosis in the pathogenesis and treatment of breast cancer. | J Transl Med | 2026 | 42458449 | PubTator, text mining | PubMed |
| A mitochondrial regulatory network of ferroptosis defense in HPV-positive cervical cancer: therapeutic implications of the mitoSTAT3-DHODH axis. | Front Pharmacol | 2026 | 42389278 | PubTator, text mining | PubMed |
| Invoking ferroptosis and photon-controlled pyroptosis via an integrated therapeutic system for triple-pathway tumor therapy. | Chem Sci | 2026 | 42388809 | PubTator, text mining | PubMed |
| DHODH Drives Sunitinib Resistance Via a Non-Enzymatic Mechanism by Inhibiting TRIM28 Ubiquitination and Consequent VEGFA Activation in RCC. | Adv Sci (Weinh) | 2026 | 42335405 | PubTator, text mining | PubMed |
| DHODH regulates trophoblast fusion via IFITM-reduced plasma membrane fluidity: Implications for hypertensive disorders of pregnancy. | iScience | 2026 | 42291278 | PubTator, text mining | PubMed |
| Machine learning-assisted screening of natural product database for the identification of novel chalcone-based derivative as a potent DHODH inhibitor in cancer therapy. | Discov Oncol | 2026 | 42283901 | PubTator, text mining | PubMed |
| The Dual Role of Ferroptosis in Cancer: Molecular Mechanisms, Microenvironment Crosstalk, and Precision Therapeutics. | Cancers (Basel) | 2026 | 42279414 | PubTator, text mining | PubMed |
| Diselenide-Bridged Iron-Porphyrin MOF for MRI-Guided Radiotherapy via Triple-Pathway Ferroptosis. | Int J Nanomedicine | 2026 | 42267311 | PubTator, text mining | PubMed |
| Virtual screening and molecular dynamics analysis of Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) inhibitors targeting pyrimidine biosynthesis pathway. | Folia Microbiol (Praha) | 2026 | 42262655 | PubTator, text mining | PubMed |
| Disrupting Notch signalling by a small molecule inhibiting dihydroorotate dehydrogenase activity. | Sci Rep | 2026 | 42251101 | PubTator, text mining | PubMed |
| CoQ10 oxidoreductases in ferroptosis and cancer: redox regulation and therapeutic opportunities. | Exp Mol Med | 2026 | 42236897 | PubTator, text mining | PubMed |
| DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity. | J Med Chem | 2026 | 42233404 | PubTator, text mining | PubMed |
| Unmasking the apoptotic potential of DHODH inhibition through targeting adaptive mitophagy. | Front Cell Dev Biol | 2026 | 42222339 | PubTator, text mining | PubMed |
| Iron-addicted colorectal cancers exploit heme-complex II axis to resist oxidative cell death. | Cell Metab | 2026 | 42202783 | PubTator, text mining | PubMed |
| Post-Translational Modification Networks in Ferroptosis: Orchestrating Defense, Drug Resistance, and Therapeutic Opportunities in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2026 | 42199338 | PubTator, text mining | PubMed |
| NFE2L2-Associated Ferroptosis Resistance Reshapes the Tumor Immune Microenvironment and Guides Therapeutic Strategies in Prostate Cancer. | Int J Mol Sci | 2026 | 42196424 | PubTator, text mining | PubMed |
| The Role of Pharmacogenetics in the Effectiveness of Rheumatoid Arthritis Treatment with Leflunomide. | Genes (Basel) | 2026 | 42195031 | PubTator, text mining | PubMed |
| Structural Basis for Potent Inhibition of Human DHODH by Quinoline-4-carboxylic Acid Derivatives. | ACS Omega | 2026 | 42146252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1723/papers?page=2